CAS: 1369764-02-2 - (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide

Formel: C₂₂H₂₀F₂N₄O₂

InChl: InChI=1S/C22H20F2N4O2/c1-13-19(11-25-14(2)27-13)30-12-22(15-4-3-5-16(23)8-15)9-18(22)21(29)28-20-7-6-17(24)10-26-20/h3-8,10-11,18H,9,12H2,1-2H3,(H,26,28,29)/t18-,22+/m0/s1

InChI Key: InChIKey=MUGXRYIUWFITCP-PGRDOPGGSA-N

SMILES: O=C(NC1=NC=C(F)C=C1)C2CC2(C=3C=CC=C(F)C3)COC4=CN=C(N=C4C)C

Synonyme:

• (1R,2S)-2-[[(2,4-Dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)cyclopropanecarboxamide
• Dayvigo
• Cyclopropanecarboxamide, 2-[[(2,4-dimethyl-5-pyrimidinyl)oxy]methyl]-2-(3-fluorophenyl)-N-(5-fluoro-2-pyridinyl)-, (1R,2S)-
• E 2006
• Lemborexant

Lemborexant

CAS: 1369764-02-2

• Formel: C₂₂H₂₀F₂N₄O₂
• Molekulargewicht: 410.42

Lemborexant-d3

CAS: 1369764-02-2

• Formel: C₂₂H₁₇D₃F₂N₄O₂
• Molekulargewicht: 413.44

Lemborexant

CAS: 1369764-02-2

• Formel: C₂₂H₂₀F₂N₄O₂
• Farbe und Form: Neat
• Molekulargewicht: 410.42

Lemborexant

CAS: 1369764-02-2

Dual orexin receptor antagonist

• Formel: C₂₂H₂₀F₂N₄O₂
• Reinheit: Min. 98 Area-%
• Farbe und Form: Powder
• Molekulargewicht: 410.42 g/mol